Back to Search
Start Over
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event.
- Source :
-
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2008 Aug; Vol. 79 (8), pp. 895-9. Date of Electronic Publication: 2007 Dec 20. - Publication Year :
- 2008
-
Abstract
- Background and Aims: Published data suggest that patients with cerebral ischaemia and atrial fibrillation (CIAF) have higher inhospital mortality than patients with cerebral ischaemia of arterial origin (CIAO). Data on long term risks are scarce. We compared the long term risks of death and vascular events (VE) between these groups.<br />Methods: We extended the follow-up of 2473 patients from the Dutch TIA Trial (recruitment March 1986 to March 1989, all treated with aspirin; CIAO) and 186 Dutch participants of the European Atrial Fibrillation Trial (recruitment June 1988 to May 1992, 26% on anticoagulants during the trial; CIAF). Hazard ratios (HRs) for death and VE of CIAF versus CIAO were analysed by means of Cox regression analysis and adjusted for age, sex and several cardiovascular risk factors.<br />Results: After a mean follow-up of 10.1 years, 1484 patients with CIAO had died and 1336 had suffered at least one VE (377 cardiac, 455 stroke). Mean follow-up of the CIAF patients was 6.8 years; 150 patients had died and 136 had suffered at least one VE (41 cardiac, 63 stroke). Adjusted HRs (CIAF vs CIAO) were 1.46 (95% CI 1.22 to 1.74) for death, 1.49 (1.24 to 1.79) for first VE, 1.94 (1.47 to 2.55) for first stroke and 1.41 (1.01 to 1.96) for first cardiac event. These HRs were essentially the same as those for the duration of the trials.<br />Conclusion: Our study shows that the long term risk of death or vascular events is 1.5 times higher in patients with CIAF than in those with CIAO, after adjustment for differences between the groups.
- Subjects :
- Aged
Anticoagulants therapeutic use
Aspirin therapeutic use
Atrial Fibrillation complications
Atrial Fibrillation drug therapy
Cause of Death
Cerebral Hemorrhage etiology
Cerebral Hemorrhage prevention & control
Cerebral Infarction etiology
Cerebral Infarction prevention & control
Cohort Studies
Death, Sudden, Cardiac etiology
Death, Sudden, Cardiac prevention & control
Disease-Free Survival
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Heart Failure etiology
Heart Failure prevention & control
Hospital Mortality
Humans
Ischemic Attack, Transient drug therapy
Ischemic Attack, Transient etiology
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction etiology
Myocardial Infarction prevention & control
Netherlands
Proportional Hazards Models
Risk Factors
Warfarin therapeutic use
Atrial Fibrillation mortality
Cerebral Hemorrhage mortality
Cerebral Infarction mortality
Death, Sudden, Cardiac epidemiology
Heart Failure mortality
Ischemic Attack, Transient mortality
Myocardial Infarction mortality
Subjects
Details
- Language :
- English
- ISSN :
- 1468-330X
- Volume :
- 79
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Journal of neurology, neurosurgery, and psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 18096680
- Full Text :
- https://doi.org/10.1136/jnnp.2007.133132